JNK

Fund Description
The SPDR Bloomberg Barclays High Yield Bond ETF seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the Bloomberg Barclays High Yield Very Liquid Index (the "Index"). Seeks to provide a a diversified exposure to US dollar-denominated high yield corporate bonds with above-average liquidity. A more cost efficient way to implement a high yield exposure than via individual bonds.
Fund Profile
Fund Name SPDR Bloomberg Barclays High Yield Bond ETF
Fund Exchange Ticker JNK
Fund Sponsor State Street (SPDR)
Fund ISIN US78464A4177
Net Expense Ratio 0.40 %
Fund Inception Date 28 November 2007
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific Bonds - Corporate
Asset Class Bonds
Index Linked Passive
Index Name Bloomberg Barclays High Yield Very Liquid Index
Index Provider Bloomberg
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Bond Type Corporate
Credit Quality High Yield
Average Maturity Fund Holds All Maturity Ranges
Bond Currency Denomination USD
Key Statistics
Return As of Date 17 January 2019
Asset Under Management 7954.23 Million (USD)
1 Month Total Return 2.44 %
Year To Date Return 4.14 %
1 Year Total Return 0.40 %
3 Year Annualized Total Return 8.34 %
NAV 34.8833
Share Outstanding 228,024,000
Top 10 Holdings (16 January 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
ALTICE FRANCE SA 7.375 05/01/2026 BOND 0.0071045700
SPRINT CORP 7.875 09/15/2023 BOND 0.0064669500
CHS/COMMUNITY HEALTH SYS BOND 0.0044629100
CCO HLDGS LLC/CAP CORP BOND 0.0043755300
INTELSAT JACKSON HLDG BOND 0.0041611300
ALTICE LUXEMBOURG SA BOND 0.0040994400
PRIME SECSRVC BRW/FINANC BOND 0.0040210400
VALEANT PHARMACEUTICALS 6.125 04/15/2025 BOND 0.0038640400
HCA INC 5.375 02/01/2025 BOND 0.0038383100
VALEANT PHARMACEUTICALS 5.875 05/15/2023 BOND 0.0038130500